GlassScriptPhysician profile
Wallace Royce Nelms
NPI 1710081161
$14,628.00
in general payments reported to CMS, 2019-2025
54 companies · $1,953 in 2025
The $1,953 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,527 · 2020: $1,568 · 2021: $2,748 · 2022: $2,132 · 2023: $2,424 · 2024: $2,276 · 2025: $1,953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,622 · Education: $31.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,621.50 |
| Education | $31.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,622.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,473.89 | 2019-2025 | Repatha, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $1,458.06 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,439.41 | 2019-2025 | |
| Lilly USA, LLC | $1,246.17 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $655.26 | 2019-2025 | Jardiance |
| Pfizer INC. | $619.63 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $451.83 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Glaxosmithkline, LLC. | $316.81 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Teva Pharmaceuticals USA, INC. | $301.78 | 2019-2023 | Ajovy |
| Bayer Healthcare Pharmaceuticals INC. | $289.96 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $236.26 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $208.73 | 2020-2025 | Xifaxan |
| Radius Health, INC. | $205.25 | 2019-2023 | Tymlos |
| Janssen Pharmaceuticals, INC | $199.67 | 2019-2023 | Xarelto |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $192.25 | 2022-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Allergan, INC. | $190.67 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $187.13 | 2019-2022 | |
| Esperion Therapeutics, INC. | $177.03 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $176.45 | 2020-2025 | |
| Amarin Pharma, INC. | $148.44 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $138.34 | 2022 | |
| Preventric Diagnostics, INC. | $124.10 | 2021-2022 | |
| Antares Pharma, INC. | $115.68 | 2019-2023 | Nocdurna, Tlando, Xyosted |
| Idorsia Pharmaceuticals US INC | $110.56 | 2022-2024 | Quviviq |
| Kowa Pharmaceuticals America, INC. | $109.28 | 2019-2025 | Zoryve, Livalo |
| Otsuka America Pharmaceutical, INC. | $105.01 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $93.27 | 2023-2024 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $89.86 | 2021-2022 | |
| Cequr Corporation | $82.07 | 2022-2023 | Cequr Simplicity |
| Biohaven Pharmaceuticals, INC. | $80.26 | 2021 | |
| Sumitomo Pharma America, INC. | $79.29 | 2023-2024 | Gemtesa |
| Tolmar, INC. | $75.06 | 2024-2025 | Jatenzo |
| Sanofi Pasteur INC. | $66.45 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $57.57 | 2024-2025 | Edarbi |
| Eisai INC. | $52.45 | 2020-2021 | |
| Halozyme INC | $49.60 | 2023 | |
| Insulet Corporation | $43.99 | 2025 | Omnipod |
| Arbor Pharmaceuticals, INC. | $39.05 | 2019-2021 | |
| Dexcom, INC. | $35.89 | 2021-2023 | Dexcom G6 Transmitter |
| Bausch Health US, LLC | $29.06 | 2021-2022 | |
| Cashflow Solutions, LLC | $27.53 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Daiichi Sankyo INC. | $26.49 | 2021 | |
| Teleflex LLC | $26.05 | 2025 | Urolift |
| Astellas Pharma US INC | $23.29 | 2024 | Veozah |
| Grifols USA, LLC | $20.30 | 2023 | Prolastin-C Liquid |
| Lundbeck LLC | $18.69 | 2024 | Rexulti |
| Seqirus USA INC | $18.53 | 2025 | Flucelvax, Fluad |
| Myriad Women'S Health, INC. | $18.19 | 2023 | Myrisk |
| Aytu Biopharma, INC. | $17.81 | 2019 | |
| Agepha Pharma Fz LLC | $15.16 | 2025 | Lodoco |
| Genentech USA, INC. | $15.06 | 2020 | |
| Mylan Specialty L.P. | $14.37 | 2022 | |
| Hikma Pharmaceuticals USA | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wallace Nelms listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.